Quattro Advisors’s Amgen AMGN Stock Holding History

Quattro Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-335	Closed	-$110K	–	84
2025 Q4	$110K	Buy	+335	New	+$106K	0.09%	70

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Quattro Advisors's AMGN Position: Q1 2026 in Review

Quattro Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 335 shares — an estimated $110K sold.

Quattro Advisors first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $110K in Q4 2025. 3,152 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Quattro Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Quattro Advisors sold 335 Amgen shares in Q1 2026, an estimated $110K.
Quattro Advisors first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
Quattro Advisors's Amgen position peaked at $110K in Q4 2025.
3,152 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Quattro Advisors's 13F filing for Q1 2026, filed 15 May 2026.